Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ARCA Biopharma Inc ABIO

Healthcare Biotechnology
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is... see more

Bullboard (NDAQ:ABIO)

View:
Post by whytestockson Apr 22, 2024 11:45pm

Expected US Company Earnings on Monday, April 22nd, 2024

Just In: $ABIO Expected US Company Earnings on Monday, April 22nd, 2024Bank of Hawaii Corporation (BOH) is expected to report $0.92 for Q1 2024 Brown @ Brown Inc. (BRO) is expected to report $1.07 for ...more  
38
Post by whytestockson Apr 03, 2024 10:45am

ARCA biopharma and Oruka Therapeutics Announce Merger Agreem

JUST IN: $ABIO ARCA biopharma and Oruka Therapeutics Announce Merger AgreementMerger to create a company focused on advancing Oruka@s portfolio of novel biologics that aim to redefine the standard of ...more  
21